01—History
Free Cash Flow History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- $7.39B
YoY changeLargest recent move+113.0%in FY17Latest +16.4%
02—Ledger
Free Cash Flow, period by period
| Period | Scale | Value | Change | Source |
|---|---|---|---|---|
| FY2025 | $7.39B | +16.4% | 10-K | |
| FY2024 | $6.35B | +25.5% | 10-K | |
| FY2023 | $5.06B | −35.2% | 10-K | |
| FY2022 | $7.80B | −9.8% | 10-K | |
| FY2021 | $8.65B | +51.1% | 10-K | |
| FY2020 | $5.72B | +27.3% | 10-K | |
| FY2019 | $4.50B | −8.3% | 10-K | |
| FY2018 | $4.91B | +10.6% | 10-K | |
| FY2017 | $4.43B | +113.0% | 10-K | |
| FY2016 | $2.08B | +12.2% | 10-K | |
| FY2015 | $1.86B | −28.6% | 10-K | |
| FY2014 | $2.60B | +19.2% | 10-K | |
| FY2013 | $2.18B | −71.0% | 10-K | |
| FY2012 | $7.52B | +0.5% | 10-K | |
| FY2011 | $7.48B | −3.1% | 10-K | |
| FY2010 | $7.72B | +24.8% | 10-K | |
| FY2009 | $6.19B | +8.4% | 10-K | |
| FY2008 | $5.71B | +61.8% | 10-K | |
| FY2007 | $3.53B | — | 10-K |
03—Questions
What is ABBOTT LABORATORIES's current free cash flow?
ABBOTT LABORATORIES (ABT) annual free cash flow for 2025 was $7.39B, a 16.44% increase from 2024. ABBOTT LABORATORIES free cash flow for the quarter ending March 31, 2026 was $916.0M.
What was ABBOTT LABORATORIES's free cash flow in 2024?
ABBOTT LABORATORIES annual free cash flow for 2024 was $6.35B, a 25.54% increase from 2023.
What was ABBOTT LABORATORIES's free cash flow in 2023?
ABBOTT LABORATORIES annual free cash flow for 2023 was $5.06B, a 35.17% decline from 2022.
What is ABBOTT LABORATORIES's 5-year free cash flow CAGR?
ABBOTT LABORATORIES free cash flow grew at a compound annual growth rate (CAGR) of 5.26% from FY2020 to FY2025, going from $5.72B to $7.39B over 5 years.
- Company
- ABBOTT LABORATORIES
- Ticker
- ABT
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations